Drugmaker Eyes Reinsurance to Lower Costs, Reports Financial Times

Swiss drugmaker Novartis AG is considering working with reinsurers to provide alternative financing options for life-saving drugs, potentially saving substantial healthcare costs, Financial Times reported on Sunday. Among the options proposed includes a “reinsurance model in which a third party …

from News – Insurance Journal